Full name
PHILIPS RESPIROMIX SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.74.Z - Retail sale of medical and orthopedic products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.41.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
71.20 - Technical testing and analysis
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,7 | -0,2 | -0,5 | -110,8 |
EBITDA | 1,4 | 0,3 | 0,2 | -30,5 |
Short time liabilities | 0,8 | 2,3 | 1,5 | -34,7 |
Equity capital | 15,9 | 12,2 | 11,8 | -3,3 |
Operating profit (EBIT) | 1,3 | -0 | -0,3 | -726,8 |
Assets | 16,9 | 14,9 | 13,8 | -7,5 |
Net profit (loss) | 0,7 | -0,2 | -0,4 | -116,9 |
Cash | 2,7 | 4,5 | 3,9 | -13,9 |
Net income from sale | 22,8 | 9,6 | 9,6 | -0,8 |
Liabilities and provisions for liabilities | 1 | 2,7 | 2 | -26,2 |
Working assets | 14,8 | 13,2 | 12,2 | -7 |
Depreciation | 0,2 | 0,3 | 0,5 | 72,6 |
% | % | % | p.p. | |
Profitability of capital | 4,2 | -1,5 | -3,4 | -1,9 |
Equity capital to total assets | 94,1 | 81,8 | 85,5 | 3,7 |
Gross profit margin | 3,2 | -2,3 | -4,8 | -2,5 |
EBITDA Margin | 6,3 | 2,6 | 1,8 | -0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 12 | 86 | 57 | -29 |
Current financial liquidity indicator | 15.49130630493164 | 4.96066427230835 | 6.704474925994873 | 1,7 |
Net dept to EBITDA | -1.8793926239013672 | -16.100921630859375 | -22.424823760986328 | -6,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane